- Home
- CNOB vs BLFS Comparison
CNOB vs BLFS Comparison
Compare CNOB & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNOB | BLFS |
|---|---|---|
| Founded | 1982 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1996 | 1989 |
Fundamental Metrics
Financial Performance| Metric | CNOB | BLFS |
|---|---|---|
| Price | $27.43 | $24.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $29.50 | ★ $32.00 |
| AVG Volume (30 Days) | 252.2K | ★ 331.2K |
| Earning Date | 01-30-2026 | 03-02-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $295,956,000.00 | $100,144,000.00 |
| Revenue This Year | $47.80 | $18.45 |
| Revenue Next Year | $31.81 | $16.27 |
| P/E Ratio | $20.23 | ★ N/A |
| Revenue Growth | 19.03 | ★ 87.53 |
| 52 Week Low | $20.61 | $19.10 |
| 52 Week High | $28.47 | $29.62 |
Technical Indicators
Market Signals| Indicator | CNOB | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.15 | 45.33 |
| Support Level | $25.78 | $23.28 |
| Resistance Level | $26.95 | $26.68 |
| Average True Range (ATR) | 0.62 | 0.99 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 90.64 | 33.58 |
Price Performance
Historical ComparisonAbout CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.